Watanabe Norio, Ebisujima Minami, Ichihara Takahiro, Ando Motozumi, Kawahara Masami
Clinical Pharmacy and Sciences, School of Pharmacy, Aichi Gakuin University, 1-100, Kusumoto-Cho, Chikusa-Ku, Nagoya, Aichi, 464-8650, Japan.
COSMOS CHOUZAI Pharmacy Co., Ltd, 5-4-14, Meieki, Nakamura-Ku, Nagoya, Aichi, 450-0002, Japan.
J Pharm Health Care Sci. 2025 May 7;11(1):38. doi: 10.1186/s40780-025-00447-0.
This study aimed to assess the prevalence of dysphagia among nursing home residents and to examine the association between medication use and impaired swallowing function.
Between January and December 2023, we conducted a retrospective survey across 14 nursing homes visited by community pharmacists. Swallowing function was evaluated using the Eating Assessment Tool-10 (EAT-10) questionnaire. Residents were categorized into two groups: those with reduced swallowing function (EAT-10 score ≥ 3) and those with normal swallowing function (EAT-10 score < 3). The association between medication use and swallowing function was analyzed using univariate and multivariate logistic regression models.
Significant differences were observed between the reduced (n = 101, 36.9%) and normal swallowing function (n = 173, 63.1%) groups in terms of age (P = 0.022), body mass index (BMI) (P < 0.001), and nursing care level (P < 0.001). Propensity score matching was performed to adjust for confounding factors, yielding 72 matched pairs. Analysis of the matched cohort revealed a significant association between antipsychotic use and reduced swallowing function (odds ratio [OR], 2.600; 95% confidence interval [CI], 1.210-5.560; P = 0.014).
This study identified a significant association between antipsychotic drug use and reduced swallowing function. Medication reviews incorporating assessments of swallowing function may help mitigate the risk of aspiration. Further prospective studies are warranted to validate these findings and to clarify causal relationship between medication use and swallowing dysfunction.
本研究旨在评估养老院居民吞咽困难的患病率,并探讨药物使用与吞咽功能受损之间的关联。
在2023年1月至12月期间,我们对社区药剂师走访的14家养老院进行了一项回顾性调查。使用进食评估工具-10(EAT-10)问卷评估吞咽功能。居民被分为两组:吞咽功能减退组(EAT-10评分≥3)和吞咽功能正常组(EAT-10评分<3)。使用单因素和多因素逻辑回归模型分析药物使用与吞咽功能之间的关联。
在年龄(P = 0.022)、体重指数(BMI)(P < 0.001)和护理级别(P < 0.001)方面,吞咽功能减退组(n = 101,36.9%)和吞咽功能正常组(n = 173,63.1%)之间存在显著差异。进行倾向得分匹配以调整混杂因素,得到72对匹配对。对匹配队列的分析显示,使用抗精神病药物与吞咽功能减退之间存在显著关联(优势比[OR],2.600;95%置信区间[CI],1.210 - 5.560;P = 0.014)。
本研究发现使用抗精神病药物与吞咽功能减退之间存在显著关联。纳入吞咽功能评估的药物审查可能有助于降低误吸风险。有必要进行进一步的前瞻性研究来验证这些发现,并阐明药物使用与吞咽功能障碍之间的因果关系。